Comprehensive molecular profiling to predict clinical outcomes in pancreatic cancer

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) has the worst prognosis among common cancers. The genomic landscape of PDAC is defined by four mutational pathways: kirsten rat sarcoma virus (KRAS), cellular tumor antigen p53 (TP53), cyclin dependent kinase inhibitor 2A (CDKN2A), and SMAD family...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Jung Yong, Cho, Hee Jin, Kim, Seung Tae, Park, Young Suk, Shin, Sang Hyun, Han, In Woong, Lee, Jeeyun, Heo, Jin Seok, Park, Joon Oh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404641/
https://www.ncbi.nlm.nih.gov/pubmed/34471425
http://dx.doi.org/10.1177/17588359211038478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404641/
https://www.ncbi.nlm.nih.gov/pubmed/34471425
http://dx.doi.org/10.1177/17588359211038478

Ejemplares similares